TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical Trial.

Andrey A Ivashchenko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.